A comparison of the scientific quality of publicly and privately funded randomized controlled drug trials

Journal of Evaluation in Clinical Practice

Volumn 16, Issue 6, 2010, Pages 1322-1325

  Jones, Richard ^a   Younie, Stuart ^a   MacAllister, Andrew ^a   Thornton, Jim ^b  

^a Foundation Year 2   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

bias; methodological quality; private sector; public sector; randomized controlled trials

Indexed keywords

ARTICLE; COCHRANE LIBRARY; COMPARATIVE STUDY; HUMAN; MEDICAL RESEARCH; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

DRUG INDUSTRY; HUMANS; PHARMACEUTICAL PREPARATIONS; PRIVATE SECTOR; PUBLIC SECTOR; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78650591486     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2009.01335.x     Document Type: Article

References (26)

1. Lexchin, J., Bero, L. A., Djulbegovic, B., &, Clark, O., (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ, 326, 1167-1170.
2. Bekelman, J. E., Li, Y., &, Gross, C. P., (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA, 289, 454-465.
3. Easterbrook, P. J., Gopalan, R., Berlin, J. A., &, Matthews, D. R., (1991) Publication bias in clinical research. Lancet, 337, 867-872.
4. Chard, J. A., Tallon, D., &, Dieppe, P. A., (2000) Epidemiology of research into interventions for the treatment of osteoarthritis of the knee joint. Annals of Rheumatic Diseases, 59, 414-418.
5. Yaphe, J., Edman, R., Knishkowy, B., &, Herman, J., (2001) The association between funding by commercial interests and study outcome in randomized controlled drug trials. Family Practice, 18, 565-568.
6. Thornton, J. G., (2006) The quality of randomised trials in tocolysis. BJOG, 113 (Suppl. 3), 93-95.
7. King, J. F., Flenady, V. J., Papatsonis, D. N. M., Dekker, G. A., &, Carbonne, B., (2003) Calcium channel blockers for inhibiting preterm labour. Cochrane Database of Systematic Reviews. Issue 1. Art. No.: CD002255. DOI: 10.1002/14651858.CD002255.
8. Duckitt, K., &, Thornton, S., (2002) Nitric oxide donors for the treatment of preterm labour. Cochrane Database of Systematic Reviews. Issue 3. Art. No.: CD002860. DOI: 10.1002/14651858.CD002860.
9. Papatsonis, D., Flenady, V., Cole, S., &, Liley, H., (2005) Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database of Systematic Reviews. Issue 3. Art. No.: CD004452. DOI: 10.1002/14651858.CD004452. pub2.
10. King, J., Flenady, V., Cole, S., &, Thornton, S., (2005) Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane Database of Systematic Reviews. Issue 2. Art. No.: CD001992. DOI: 10.1002/14651858. CD001992.pub2.
11. Crowther, C. A., &, Moore, V., (1998) Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour. Cochrane Database of Systematic Reviews. Issue 1. Art. No.: CD000940. DOI: 10.1002/14651858. CD000940.
12. Dodd, J. M., Crowther, C. A., Dare, M. R., &, Middleton, P., (2006) Oral betamimetics for maintenance therapy after threatened preterm labour. Cochrane Database of Systematic Reviews. Issue 1. Art. No.: CD003927. DOI: 10.1002/14651858.CD003927.pub2.
13. Lip, G. Y. H., &, Felmeden, D. C., (2004) Antiplatelet agents and anticoagulants for hypertension. Cochrane Database of Systematic Reviews. Issue 3. Art. No.: CD003186. DOI: 10.1002/14651858.CD003186.pub2.
14. Wiysonge, C. S., Bradley, H., Mayosi, B. M., Maroney, R., Mbewu, A., Opie, L. H., &, Volmink, J., (2007) Beta-blockers for hypertension. Cochrane Database of Systematic Reviews. Issue 1. Art. No.: CD002003. DOI: 10.1002/14651858.CD002003.pub2. (Pubitemid 351835436)
15. Mulrow, C., Lau, J., Cornell, J., &, Brand, M., (1998) Pharmacotherapy for hypertension in the elderly. Cochrane Database of Systematic Reviews. Issue 2. Art. No.: CD000028. DOI: 10.1002/14651858.CD000028.
16. Quan, A., Kerlikowske, K., Gueyffier, F., Boissel, J. P., for the INDANA Investigators (2000) Pharmacotherapy for hypertension in women of different races. Cochrane Database of Systematic Reviews. Issue 2. Art. No.: CD002146. DOI: 10.1002/14651858.CD002146.
17. Alderson, P., Green, S., &, Higgins, J., (eds) (2004) Assessment of study quality. Cochrane Reviewers' Handbook 4.2.3; Section 6. Available at: [last accessed November 2004.
18. Moher, D., Cook, D. J., Jadad, A. R., Tugwell, P., Moher, M., Jones, A., Pham, B., Klassen, T. P., (1999) Assessing the quality of reports of randomized trials: implications for the conduct of meta-analyses. Health Technology Assessment, 3 (12), 1-90.
19. Rochon, P. A., Gurwitz, J. H., Cheung, M., Hayes, J. A., &, Chalmers, T. C., (1994) Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA, 272, 108-113.
20. Cho, M. K., &, Bero, L. A., (1996) The quality of drug studies published in symposium proceedings. Annals of Internal Medicine, 124, 485-489.
21. Davidson, R. A., (1986) Source of funding and outcome of clinical trials. Journal of General Internal Medicine, 1 (3), 155-158.
22. Djulbegovic, B., Lacevic, M., Cantor, A., Fields, K. K., Bennett, C. L., Adams, J. R., Kuderer, N. M., &, Lyman, G. H., (2000) The uncertainty principle and industry-sponsored research. Lancet, 356, 635-638.
23. Kjaergard, L. L., Nikolova, D., &, Gluud, C., (1999) Randomized clinical trials in Hepatology: predictors of quality. Hepatology, 30, 134-1138.
24. Mandelkern, M., (1999) Manufacturer support and outcome. Journal of Clinical Psychiatry, 60, 122-123.
25. Massie, B. M., &, Rothenberg, D., (1993) Publication of sponsored symposiums in medical journals. The New England Journal of Medicine, 328, 1196-1197.
26. Kealey, T., (1996) The Economic Laws of Scientific Research. London: Palgrave Macmillan.